AJMC February 22, 2023
Angela Storseth-Cooper, Lalan Wilfong, MD

When treating patients with complex health care needs, particularly those living with cancer, time is of the essence. So, too, is access to personalized medicine.

Clinical decisions regarding the specific treatments, therapies, and medications used in the course of oncological care should be patient centered, physician driven, and evidence based. That is why community oncology practices, in partnership with The US Oncology Network and the National Comprehensive Cancer Network, developed a set of evidence-based, physician-led Value Pathways to improve the quality of cancer care and significantly reduce costs.1

Unfortunately, not everyone shares these values. Cost-containing measures and profit-driven decisions made by health insurers, as well as their affiliated pharmacy benefit managers (PBMs) and specialty pharmacies, often dictate the care patients...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article